Related references
Note: Only part of the references are listed.Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturation
Sabine Heublein et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
Sabine Heublein et al.
JOURNAL OF OVARIAN RESEARCH (2013)
The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells
Gui-Qiang Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer
Venkatakrishna Rao Jala et al.
BMC CANCER (2012)
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
Miriam Lenhard et al.
BMC CANCER (2012)
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
Miriam Lenhard et al.
BMC CANCER (2012)
Estrogen Receptors Are Found in Glia and at Extranuclear Neuronal Sites in the Dorsal Striatum of Female Rats: Evidence for Cholinergic But Not Dopaminergic Colocalization
Anne Almey et al.
ENDOCRINOLOGY (2012)
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
Rupert Bartsch et al.
EUROPEAN JOURNAL OF CANCER (2012)
Puerarin Suppresses Proliferation of Endometriotic Stromal Cells Partly via the MAPK Signaling Pathway Induced by 17β-estradiol-BSA
Wen Cheng et al.
PLOS ONE (2012)
The G-Protein-Coupled Estrogen Receptor (GPER) is Expressed in Normal Human Ovaries and is Upregulated in Ovarian Endometriosis and Pelvic Inflammatory Disease Involving the Ovary
Sabine Heublein et al.
REPRODUCTIVE SCIENCES (2012)
The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
Zuzana Kolkova et al.
JOURNAL OF OVARIAN RESEARCH (2012)
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
Satoe Fujiwara et al.
JOURNAL OF OVARIAN RESEARCH (2012)
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
Atanas Ignatov et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Induction of G protein-coupled estrogen receptor (GPER) and nuclear steroid hormone receptors by gonadotropins in human granulosa cells
Roman Pavlik et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2011)
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Miriam Lenhard et al.
HISTOPATHOLOGY (2011)
The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells
Eric A. Ariazi et al.
CANCER RESEARCH (2010)
Are gonadotrophins tumorigenic-A critical review of clinical and experimental data
Ilpo Huhtaniemi
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Tamoxifen for relapse of ovarian cancer
Chris Williams et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors
Hugo Arias-Pulido et al.
GYNECOLOGIC ONCOLOGY (2009)
A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer
Peter A. Argenta et al.
GYNECOLOGIC ONCOLOGY (2009)
GPR30 predicts poor survival for ovarian cancer
Harriet O. Smith et al.
GYNECOLOGIC ONCOLOGY (2009)
Estrogen regulation of gene expression in GnRH neurons
Yewade Ng et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission
Douglas Levine et al.
CANCER (2007)
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy- : A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)
Uwe Wagner et al.
GYNECOLOGIC ONCOLOGY (2007)
FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor
Y. Li et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
Hakan Karagol et al.
MEDICAL ONCOLOGY (2007)
Estrogen receptor beta 1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells
Oliver Treeck et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression
Edward J. Filardo et al.
CLINICAL CANCER RESEARCH (2006)
Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells
Jung-Hye Choi et al.
ENDOCRINE-RELATED CANCER (2006)
Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen
AJM O'Donnell et al.
ENDOCRINE-RELATED CANCER (2005)
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
J Hasan et al.
BRITISH JOURNAL OF CANCER (2005)
Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells
Q Ji et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells
JH Choi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Potentiation of GPCR-signaling via membrane targeting of G protein α subunits
E Kostenis
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer
JJ Lu et al.
GYNECOLOGIC ONCOLOGY (2000)
Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone
WX Zheng et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
